← FDA Drug Approvals (Drugs@FDA)
SULAR
NDA · New Drug Application · Sponsor: AZURITY · Approved 1995-02-02
Drug application
- FDA Application #
NDA020356- Application type
- New Drug Application
- Brand name
- SULAR
- Generic name
- NISOLDIPINE
- Active ingredients
- NISOLDIPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AZURITY
- Manufacturer
- Prasco Laboratories
- First approval
- 1995-02-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown